Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,480.00
0.00 (0.00%)
At close: Sep 11, 2026

Korea Arlico Pharm Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
195,703201,204190,436187,155167,737140,157
Revenue Growth
-3.03%5.65%1.75%11.58%19.68%12.30%
Gross Profit
99,673104,23099,728110,116106,86687,485
Operating Income
-8,016989.24-5,1593,0739,8644,794
Net Income
-2,851-605.35-5,3583,0618,0344,930
Earnings Per Share
-190.51-40.32-357.00104.00532.00327.00
EPS Growth
----80.45%62.69%-41.08%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
23,04320,99319,19430,79032,20328,747
Total Debt
43,21749,04450,45746,28931,09612,601
Net Cash (Debt)
-20,174-28,051-31,263-15,4991,10716,146
Net Cash Growth
-----93.14%64.53%
Net Cash Per Share
-1347.99-1868.42-2082.99-526.6273.291071.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
17,7789,995-8,5837,1484,8368,967
Capital Expenditures
-2,216-3,112-3,501-23,385-18,974-5,268
Free Cash Flow
15,5626,883-12,085-16,237-14,1373,699
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
50.93%51.80%52.37%58.84%63.71%62.42%
Operating Margin
-4.10%0.49%-2.71%1.64%5.88%3.42%
Pretax Margin
-3.23%-0.54%-3.24%1.86%5.00%4.00%
Profit Margin
-1.46%-0.30%-2.81%1.64%4.79%3.52%
FCF Margin
7.95%3.42%-6.35%-8.68%-8.43%2.64%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---28.5412.5023.88
P/FCF Ratio
2.449.52---31.82
PS Ratio
0.190.330.280.470.600.84